Affiliation:
1. The Affiliated Ganzhou Hospital of Nanchang University
2. People's Hospital of Huichang County
3. Nanfang Hospital, Southern Medical University
Abstract
Abstract
Objective: This study aimed to investigate the association between the presence of the hyperdense middle cerebral artery sign (HMCAS) on pre-treatment non-contrast CT (NCCT) scans and the subsequent occurrence of poor functional outcomes and hemorrhagic transformation (HT) in patients with acute ischemic stroke due to large vessel occlusion (AIS-LVO) attributed to cardioembolic etiology, following mechanical thrombectomy (MT).
Methods: We conducted a retrospective analysis using patient data from the multicenter clinical trial known as MONFIS-ET, focusing on individuals with cardioembolic (CE) and large-artery atherosclerotic (LAA) occlusive strokes. Patients were categorized into four groups based on the presence of HMCAS and the underlying stroke etiology. We compared the 90-day modified Rankin score (mRS) and the incidence of HT between those with HMCAS and those without it, stratified by etiology.
Results: A total of 269 patients were included in the study, of which 85 (31.6%) exhibited HMCAS on NCCT scans. Patients without HMCAS demonstrated more favorable clinical outcomes compared to those with HMCAS (56.0% vs. 41.2%, p=0.024). Specifically, patients with HMCAS associated with cardioembolism (CE) had a less favorable outcome (20% vs. 46.7%, p=0.013) and a higher incidence of HT (65.7% vs. 33.3%, p=0.004). Conversely, there was no significant difference in prognosis between patients with HMCAS and those without it in the context of large artery atherosclerosis (58.2% vs. 57.7%, p=0.959). In multivariate logistic regression analysis, the HMCAS independently predicted poor prognosis in patients who underwent MT due to CE (OR: 4.054, 95% CI: 1.161-14.159, p=0.028).
Conclusion: In patients with AIS-LVO attributed to cardioembolic etiology who underwent MT, the presence of HMCAS on initial NCCT scans was found to be associated with an unfavorable outcome and a higher incidence of HT.
Clinical Trial Registration: ChiCTR 2300074368(retrospectively registered).
Publisher
Research Square Platform LLC
Reference35 articles.
1. Hyperdense middle cerebral artery: incidence and quantitative significance;Tomsick TA;Neuroradiology,1989
2. An early CT sign of ischemic infarction: increased density in a cerebral artery;Pressman BD;AJR Am J Roentgenol,1987
3. Hyperdense middle cerebral artery sign on admission CT scan–prognostic significance for ischaemic stroke patients treated with intravenous thrombolysis in the safe implementation of thrombolysis in Stroke International Stroke Thrombolysis Register;Kharitonova T,2009
4. Effect of alteplase on the CT hyperdense artery sign and outcome after ischemic stroke;Mair G;Neurology,2016
5. Hyperdense middle cerebral artery sign in large cerebral infarction;Hou J;Brain Behav,2021